Quarterly report pursuant to Section 13 or 15(d)

Other Comments

v3.22.2.2
Other Comments
9 Months Ended
Sep. 30, 2022
Unusual or Infrequent Items, or Both [Abstract]  
Other Comments Other Comments
COVID-19 Update
As a provider of an essential healthcare service, the Company has substantially maintained its operations, without significant disruption to serve its patients and franchisees, demonstrating top-line growth while managing through the effect of the COVID-19 pandemic to-date. Throughout the pandemic, the Company has generally maintained its workforce and operational
capacity, as well as investments in brand building. The effects of COVID-19 continue to evolve, and the Company is unable to accurately predict the future potential impacts of the pandemic on its business and operations due to uncertainties including, but not limited to, recurrence of the disease, actions taken by governmental authorities in response to the evolving pandemic, any ongoing effects on patient behavior and spending patterns or other direct and indirect impacts of the pandemic such as supply chain disruptions. Until the COVID-19 pandemic has been fully resolved as a public health crisis, it retains the potential to cause further and more severe disruption of global and national economies. The Company will continue to actively monitor the situation and may take further actions that alter its business operations as may be required by federal, state, or local authorities or that it determines are in the best interests of its employees and patients.